South & Central America Flowable Hemostats Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - Regional Analysis - by Material (Porcine Gelatin and Bovine Gelatin), Product (Active Hemostats, Passive Hemostats, and Combination Hemostats), Application (General Surgery, Cardiac Surgery, Vascular Surgery, Orthopedic Surgery, Neuro & Spine Surgery, and Others), and End User (Hospital & Clinics, Ambulatory Surgery Centers, and Others)

No. of Pages: 118    |    Report Code: BMIRE00029828    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Flowable Hemostats Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. South & Central America Flowable Hemostats Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. South & Central America Flowable Hemostats Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Number of Injuries and Surgical Procedures Favors the Market Growth
5.2 Market Opportunities
  • 5.2.1 Increasing Number of Hospitals and Surgical Centers Creates Significant Opportunities in the Market
5.3 Future Trends
  • 5.3.1 Research and Development (R&D) Activities Leading to Product Innovations
5.4 Impact of Drivers and Restraints

6. South & Central America Flowable Hemostats Market Regional Analysis

6.1 South & Central America Flowable Hemostats Market Overview
6.2 South & Central America Flowable Hemostats Market Revenue 2020-2028 (US$ Million)
6.3 South & Central America Flowable Hemostats Market Forecast Analysis

7. South & Central America Flowable Hemostats Market Analysis – by Material

7.1 Porcine Gelatin
  • 7.1.1 Overview
  • 7.1.2 Porcine Gelatin: South & Central America Flowable Hemostats Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Bovine Gelatin
  • 7.2.1 Overview
  • 7.2.2 Bovine Gelatin: South & Central America Flowable Hemostats Market – Revenue and Forecast to 2031 (US$ Million)

8. South & Central America Flowable Hemostats Market Analysis – by Product

8.1 Active Hemostats
  • 8.1.1 Overview
  • 8.1.2 Active Hemostats: South & Central America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Passive Hemostats
  • 8.2.1 Overview
  • 8.2.2 Passive Hemostats: South & Central America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Combination Hemostats
  • 8.3.1 Overview
  • 8.3.2 Combination Hemostats: South & Central America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)

9. South & Central America Flowable Hemostats Market Analysis – by Application

9.1 General Surgery
  • 9.1.1 Overview
  • 9.1.2 Combination Hemostats: South & Central America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Cardiac Surgery
  • 9.2.1 Overview
  • 9.2.2 Combination Hemostats: South & Central America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Vascular Surgery
  • 9.3.1 Overview
  • 9.3.2 Combination Hemostats: South & Central America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Orthopedic Surgery
  • 9.4.1 Overview
  • 9.4.2 Combination Hemostats: South & Central America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Neuro & Spine Surgery
  • 9.5.1 Overview
  • 9.5.2 Combination Hemostats: South & Central America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)

10. South & Central America Flowable Hemostats Market – South and Central America Analysis

10.1 South and Central America
  • 10.1.1 South & Central America Flowable Hemostats Market Breakdown, by Key Country, 2023 and 2028 (%)
  • 10.1.1.1 South & Central America Flowable Hemostats Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 Brazil: South & Central America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 Brazil: South & Central America Flowable Hemostats Market Breakdown, by Material
    • 10.1.1.1.2 Brazil: South & Central America Flowable Hemostats Market Breakdown, by Product
    • 10.1.1.1.3 Brazil: South & Central America Flowable Hemostats Market Breakdown, by Application
  • 10.1.1.2 Argentina: South & Central America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Argentina: South & Central America Flowable Hemostats Market Breakdown, by Material
    • 10.1.1.2.2 Argentina: South & Central America Flowable Hemostats Market Breakdown, by Product
    • 10.1.1.2.3 Argentina: South & Central America Flowable Hemostats Market Breakdown, by Application
  • 10.1.1.3 Rest of South and Central America : South & Central America Flowable Hemostats Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Rest of South and Central America : South & Central America Flowable Hemostats Market Breakdown, by Material
    • 10.1.1.3.2 Rest of South and Central America : South & Central America Flowable Hemostats Market Breakdown, by Product
    • 10.1.1.3.3 Rest of South and Central America : South & Central America Flowable Hemostats Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. South & Central America Flowable Hemostats Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Baxter International Inc
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Ethicon (Johnson & Johnson)
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Pfizer Inc.
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Teleflex Incorporated
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 3-D Matrix Medical Technology
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Aegis Lifesciences
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - S Market

1. Baxter International Inc

2. Ethicon (Johnson & Johnson)

3. Pfizer Inc.

4. Teleflex Incorporated

5. 3-D Matrix Medical Technology

6. Aegis Lifesciences

south-and-central-america-flowable-hemostats-market